This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

STOCKHOLM - Diamyd Medical has finalized the clinical database for an interim efficacy analysis in its phase 3 trial DIAGNODE-3, evaluating retogatein in individuals with stage 3 type 1 diabetes, ...

STOCKHOLM, Feb. 24, 2026 /PRNewswire/ -- The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) ...

LOS ANGELES (KABC) -- For decades, treatments for lupus, which affects 1.5 million Americans, have been few and far between. The condition affects mainly women and can be debilitating. Now, a ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company ...

The researchers found that 82 of the 1359 catalog records examined in October 2025 were previously updated at least monthly, with their status classified as either current or paused. HealthDay News — ...

Nearly half of CDC-run public databases on federal health surveillance stopped or delayed updates in 2025, including many webpages on vaccinations, according to a study published Jan. 27 in Annals of ...

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier ...

I wrote in the summer about changing the disease-modifying therapy (DMT) for my multiple sclerosis (MS). I’ve familiarized myself with the available DMTs, and I plan to ask my neurologist for her ...

Interested in participating in exercise research? We are looking for volunteers for various exercise-based studies to help understand the role of exercise as medicine at the molecular, cellular and ...

Introduction Non-inferiority (NI) trial designs, which assess whether an experimental intervention is no worse than the standard of care, have become increasingly prevalent in recent years. Current ...